Printer Friendly Version  View printer-friendly version
<< Back
Array BioPharma To Present At The Morgan Stanley 2014 Global Healthcare Conference

BOULDER, Colo., Sept.  3, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Morgan Stanley 2014 Global Healthcare Conference in New York City.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   


Morgan Stanley 2014 Global Healthcare Conference


Ron Squarer, Chief Executive Officer


Wednesday, September 10, 2014


12:55 p.m. Eastern Time


Grand Hyatt New York


About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Phase 3 or pivotal studies are already in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis).  For more information on Array, please go to


Tricia Haugeto

Array BioPharma Inc.



Logo -

SOURCE Array BioPharma

ShareThis Copy and Paste